01.08.2003, Tallinna Farmaatsiatehas, TLN

Tallinna Farmaatsiatehas      NEWS RELEASE                      08/01/2003



ADDITIONAL INFORMATION 



Decrease of export turnover of Tallinn Pharmaceutical Plant 



The first half-year 2003 export turnover of Tallinn Pharmaceutical Plant 

decreased approximately 24% compared to year 2002 same period. Decrease of 

export turnover is caused by reorganization of tablet production, change 

of the tablets` sale and offset system (into year 2002 sales turnover had 

been considered 100% of ointment, injection and tablet net sales, in year 

2003 net sales has been indicated only the sales of ointments and 

injections). Sales of tablets will be accounted separately and sales number 

will make up a sales revenue, which will be equal to 23% royalty (from 

tablets` net sales).      





Planned profit and profitability in year 2003



By the budget the planned profit of Tallinn Pharmaceutical Plant for year 

2003 is 7,9 mill EEK. The Board of Pharmaceutical Plant thinks that 

fulfillment of budget is workable.

In company`s long term develpoment perspective in concern frames it is 

important to increase company`s turnover and profitability (one of the 

most imoprtant purposes is to raise profitability 15-18% at the end of 

year 2005). To attain an object Tallinn Pharmaceutical Plant should 

mobilize all the resources of company and concern.

    



Ibraim Muhtsi

Director

+372 6120201